Alonso Krangle LLP Reports that Yaz, Yasmin Settlements Continue to Climb, with Nearly 1,900 Yaz and Yasmin Blood Clot Lawsuits Settled So Far

Share Article

According to Bayer AG’s Latest Stockholder Letter, the Company has Paid $402.6 Million to Settle Yaz and Yasmin Lawsuits Alleging the Oral Contraceptives Caused Blood Clots that Can Lead to Heart Attacks and Strokes.

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction accidents, nursing home abuse, medical malpractice, whistleblower

Alonso Krangle LLP - Fighting for victims of personal injury cases, defective drug and medical device litigation, construction accidents, nursing home abuse, medical malpractice, whistleblower

Alonso Krangle LLP continues to offer free yaz blood clot lawsuit evaluations and yasmin blood clot lawsuit evaluations to alleged victims of Yaz and Yasmin side effects!

Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a law firm dedicated to fighting for the rights of serious personal injury victims, are pleased to report that Bayer AG has settled nearly 1,900 lawsuits alleging that the Yaz and Yasmin birth control pills caused life-threatening blood clots that can lead to heart attacks and strokes. According to a report from Bloomberg News, Bayer AG announced the settlements in its latest stockholder newsletter, issued on July 31. [bloomberg.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-6-million.html]

Andres Alonso is serving as a member of the Plaintiffs Steering Committee the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100) currently pending in U.S. District Court, Southern District of Illinois. According to Mr. Alonso, there is still time for young women injured by Yaz or Yasmin to file lawsuits seeking compensation for their injuries. Alonso Krangle continues to offer FREE Yaz and Yasmin lawsuit consultations to anyone who may have suffered a serious side effect associated with the use of Yaz and Yasmin, including:

  •         Venous Thromboembolism ( Blood Clots )
  •         Deep vein thrombosis
  •         Pulmonary embolism
  •         Heart attacks
  •         Strokes

To discuss a potential claim with one of the experienced and compassionate defective drug lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.
According to the Bloomberg report, Bayer has paid $402.6 million to settle claims that Yaz and Yasmin caused venous blood clots, with the average settlement amounting to around $212,000. The company also said it has set aside $610 million to settle additional Yaz and Yasmin claims. Those funds will cover the company’s costs beyond what insurance will cover for legal fees and accords. About 12,000 Yaz and Yasmin claims are pending against Bayer in the federal litigation, as well as various state courts. According to Bloomberg, about half of those involve venous blood clot injuries. Bayer has so far not settled any lawsuits claiming that Yaz or Yasmin caused clots in patients’ arteries, or claims involving gall bladder injuries.

Yaz and Yasmin both contain ethinyl estradiol, along with a synthetic progestin called drospirenone. In a Drug Safety Communication issued on April 10, 2012, the U.S. Food & Drug Administration (FDA) said it was requiring that the labels for drospirenone birth control pills be updated to warn that these contraceptives may be linked to a higher risk of blood clots. Among other things, the new label includes information regarding an FDA-funded study which suggested an approximately 1.5-fold increase in the risk of blood clots among women who use drospirenone-containing pills compared to users of other hormonal contraceptives. [http://www.fda.gov/Drugs/DrugSafety/ucm273021.htm

Most recently, a New England Journal of Medicine study conducted by scientists in Denmark found that women taking low-dose estrogen birth control pills combined with progestins, such as Yaz and Yasmin, suffered heart attacks and strokes between 1.5 and 2 times more often than women not using hormonal contraception. The study analyzed 15 years of observational data from more than 1.6 million women aged 15 to 49. The highest risks were seen in women over 45, or those who had high blood pressure. [nejm.org/doi/full/10.1056/NEJMoa1111840?query=featured_home]

Alonso Krangle LLP continues to offer free lawsuit evaluations to users of Yaz and Yasmin who have suffered serious injuries, including heart attacks, strokes and blood clots. To discuss a potential claim with one of the defective drug lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website http://www.FightForVictims.com

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com

Contact:
Alonso Krangle LLP
445 Broad Hollow Road Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website